ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,580,443 | -84.8% | 107,653 | -89.3% | 0.01% | -87.2% |
| Q4 2022 | $17,031,826 | +238.6% | 1,004,235 | +195.9% | 0.05% | +213.3% |
| Q3 2022 | $5,030,000 | +2858.8% | 339,383 | +3039.8% | 0.02% | +1400.0% |
| Q2 2022 | $170,000 | -85.1% | 10,809 | -59.4% | 0.00% | -87.5% |
| Q3 2020 | $1,142,000 | -80.2% | 26,628 | -78.4% | 0.01% | -84.0% |
| Q2 2020 | $5,766,000 | – | 123,378 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |